Human Vaccines & Immunotherapeutics, Volume 10, Issue 5 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Human Vaccines & Immunotherapeutics, Volume 10, Issue 5 (2014)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Volume 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs

Editor's Corner

Editorial
Letter from the Editor
Ronald W. Ellis & Eva M. Riedmann
Pages: 1137-1138
Published online: 01 May 2014
CitationforLetter from the Editor | PDF (137.9 KB)
  • 182 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
Human Vaccines & Immunotherapeutics: News
Eva M. Riedmann
Pages: 1139-1142
Published online: 01 May 2014
AbstractforHuman Vaccines & Immunotherapeutics: News | PDF (167.1 KB)
  • 261 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Portrait

Novel vaccine technology and the future of vaccine science
Pages: 1143-1146
Published online: 01 May 2014
AbstractforNovel vaccine technology and the future of vaccine science | PDF (674.1 KB)
  • 322 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults
Lars Toft, Martin Tolstrup, Martin Müller, Peter Sehr, Jesper Bonde, Merete Storgaard, Lars Østergaard & Ole S Søgaard
Pages: 1147-1154
Published online: 19 Feb 2014
AbstractforComparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults | Full Text | References | PDF (1.1 MB)
  • 3086 Views
  • 39 CrossRef citations
  • 0Altmetric
Free Access
Article
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination
Results from a randomized study
Barbara Romanowski, Tino F Schwarz, Linda M Ferguson, Murdo Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Ulrich Behre, Pemmaraju Suryakiran, Florence Thomas & Frank Struyf
Pages: 1155-1165
Published online: 27 Feb 2014
AbstractforImmune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination | Full Text | References | PDF (2.9 MB)
  • 2674 Views
  • 73 CrossRef citations
  • 0Altmetric
Open Access

Commentary

The internet’s role in HPV vaccine education
Pooja R Patel & Abbey B Berenson
Pages: 1166-1170
Published online: 19 Feb 2014
AbstractforThe internet’s role in HPV vaccine education | Full Text | References | PDF (627 KB)
  • 2049 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
Karen M Clements, Genevieve Meier, Lisa J McGarry, Narin Pruttivarasin & Derek A Misurski
Pages: 1171-1180
Published online: 07 Mar 2014
AbstractforCost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States | Full Text | References | PDF (823.5 KB) | Supplemental
  • 3312 Views
  • 50 CrossRef citations
  • 0Altmetric
Free Access
Article
Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine
Hye-Lim Park, Seung-Hyun Shim, Eun-Young Lee, Whajung Cho, Sooho Park, Hyun-Jung Jeon, Sun-Young Ahn, Hun Kim & Jae-Hwan Nam
Pages: 1181-1186
Published online: 10 Mar 2014
AbstractforObesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine | Full Text | References | PDF (1.1 MB)
  • 2872 Views
  • 80 CrossRef citations
  • 0Altmetric
Free Access
Article
Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus
With special reference to age, body mass index, and HbA1c
Yumi Egawa, Satoko Ohfuji, Wakaba Fukushima, Yuko Yamazaki, Tomoaki Morioka, Masanori Emoto, Kazuhiro Maeda, Masaaki Inaba & Yoshio Hirota
Pages: 1187-1194
Published online: 09 Apr 2014
AbstractforImmunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus | Full Text | References | PDF (678.1 KB)
  • 948 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age
Ted M Ross, Chyongchiou Jeng Lin, Mary Patricia Nowalk, Hsin-Hui Huang, Sarah M Spencer, David K Shay, Suryaprakash Sambhara, Maria E Sundaram, Thomas Friedrich, Sandy Sauereisen, Chalise E Bloom & Richard K Zimmerman
Pages: 1195-1203
Published online: 10 Mar 2014
AbstractforInfluence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age | Full Text | References | PDF (986.4 KB)
  • 942 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Influenza vaccination coverage among medical residents
An Italian multicenter survey
Claudio Costantino, Walter Mazzucco, Elena Azzolini, Cesare Baldini, Margherita Bergomi, Alessio Daniele Biafiore, Manuela Bianco, Lucia Borsari, Paolo Cacciari, Chiara Cadeddu, Paola Camia, Eugenia Carluccio, Andrea Conti, Chiara De Waure, Valentina Di Gregori, Leila Fabiani, Roberto Fallico, Barbara Filisetti, Maria E Flacco, Elisabetta Franco, Roberto Furnari, Veronica Galis, Maria R Gallea, Maria F Gallone, Serena Gallone, Umberto Gelatti, Francesco Gilardi, Anna R Giuliani, Orazio C Grillo, Niccolò Lanati, Silvia Mascaretti, Antonella Mattei, Rocco Micò, Laura Morciano, Nicola Nante, Giuseppe Napoli, Carmelo Nobile, Raffaele Palladino, Salvatore Parisi, Maria Passaro, Gabriele Pelissero, Michele Quarto, Walter Ricciardi, Gabriele Romano, Ennio Rustico, Anita Saponari, Francesco S Schioppa, Carlo Signorelli, Roberta Siliquini, Valeria Trabacchi, Maria Triassi, Alessia Varetta, Andrea Ziglio, Angela Zoccali, Francesco Vitale & Emanuele Amodio
Pages: 1204-1210
Published online: 06 Mar 2014
AbstractforInfluenza vaccination coverage among medical residents | Full Text | References | PDF (864.8 KB)
  • 1330 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access
Article
Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses
Junwei Li, Maria T Arévalo, Yanping Chen, Olivia Posadas, Jacob A Smith & Mingtao Zeng
Pages: 1211-1220
Published online: 14 Mar 2014
AbstractforIntranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses | Full Text | References | PDF (1.3 MB)
  • 1133 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
Immune responses induced by T-cell vaccination in patients with rheumatoid arthritis
Irina Ivanova, Galina Seledtsova, Sergey Mamaev, Alexey Shishkov & Viktor Seledtsov
Pages: 1221-1227
Published online: 14 Mar 2014
AbstractforImmune responses induced by T-cell vaccination in patients with rheumatoid arthritis | Full Text | References | PDF (398.5 KB)
  • 1060 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant
Claudia Petrarca, Emanuela Clemente, Valentina Toto, Manuela Iezzi, Cosmo Rossi, Stefania Zanotta, Gianni Mistrello, Ivan Zanoni, Francesca Granucci, Stefania Arioli, Diego Mora, Simone Guglielmetti, Roberto Paganelli & Mario Di Gioacchino
Pages: 1228-1237
Published online: 06 Mar 2014
AbstractforrBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant | Full Text | References | PDF (1.7 MB) | Supplemental
  • 769 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity
Nayara TS Doimo, Carlos R Zárate-Bladés, Rodrigo F Rodrigues, Cristiane Tefé-Silva, Marcele NS Trotte, Patrícia RM Souza, Luana S Soares, Wendy M Rios, Elaine M Floriano, Izaira T Brandão, Ana P Masson, Verônica Coelho, Simone G Ramos & Celio L Silva
Pages: 1238-1243
Published online: 07 Mar 2014
AbstractforImmunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity | Full Text | References | PDF (1.1 MB)
  • 764 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Immunologic biomarkers in prostate cancer
The AE37 paradigm
Constantin N Baxevanis, Michael Papamichail & Sonia A Perez
Pages: 1244-1247
Published online: 19 Feb 2014
AbstractforImmunologic biomarkers in prostate cancer | Full Text | References | PDF (640.9 KB)
  • 649 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines
Hayk Davtyan, Andrew Bacon, Irina Petrushina, Karen Zagorski, David H Cribbs, Anahit Ghochikyan & Michael G Agadjanyan
Pages: 1248-1255
Published online: 13 Feb 2014
AbstractforImmunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines | Full Text | References | PDF (794.8 KB)
  • 1729 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
The yellow fever 17D virus as a platform for new live attenuated vaccines
Myrna C Bonaldo, Patrícia C Sequeira & Ricardo Galler
Pages: 1256-1265
Published online: 19 Feb 2014
AbstractforThe yellow fever 17D virus as a platform for new live attenuated vaccines | Full Text | References | PDF (967.8 KB)
  • 3161 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line
Erxia Yang, Chen Cheng, Ying Zhang, Jingjing Wang, Yanchun Che, Jing Pu, Chenghong Dong, Longding Liu, Zhanlong He, Shuaiyao Lu, Yuan Zhao, Li Jiang, Yun Liao, Congwen Shao & Qihan Li
Pages: 1266-1273
Published online: 28 Feb 2014
AbstractforComparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line | Full Text | References | PDF (1.3 MB) | Supplemental
  • 1075 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice
Jue Hou, Ying Liu, Jenny Hsi, Hongzhi Wang, Ran Tao & Yiming Shao
Pages: 1274-1283
Published online: 14 Mar 2014
AbstractforCholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice | Full Text | References | PDF (1.7 MB)
  • 1445 Views
  • 30 CrossRef citations
  • 0Altmetric
Free Access
Article
Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis
Dafei Chai, Yan Yue, Wei Xu, Chunsheng Dong & Sidong Xiong
Pages: 1284-1294
Published online: 10 Mar 2014
AbstractforMucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis | Full Text | References | PDF (3.8 MB)
  • 1045 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Article
Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant
Zhiqing Duan, Yunqing Duan, Huangui Lei, Ningzhu Hu, Jiandong Shi, Dong Shen, Xi Wang & Yunzhang Hu
Pages: 1295-1305
Published online: 28 Feb 2014
AbstractforAttenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant | Full Text | References | PDF (2.4 MB) | Supplemental
  • 705 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Safety and efficacy of DNA vaccines
Plasmids vs. minicircles
Sofia Stenler, Pontus Blomberg & CI Edvard Smith
Pages: 1306-1308
Published online: 19 Feb 2014
AbstractforSafety and efficacy of DNA vaccines | Full Text | References | PDF (604.7 KB)
  • 3413 Views
  • 39 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Recent advances in oral vaccine development
Yeast-derived β-glucan particles
Rebecca De Smet, Liesbeth Allais & Claude A Cuvelier
Pages: 1309-1318
Published online: 19 Feb 2014
AbstractforRecent advances in oral vaccine development | Full Text | References | PDF (1.3 MB)
  • 3994 Views
  • 58 CrossRef citations
  • 0Altmetric
Free Access

Reply Letter

Article Commentary
The stubborn persistence of adult pneumococcal pneumonia as a public health problem
Rosalind Hollingsworth & Raul Isturiz
Pages: 1319-1321
Published online: 19 Feb 2014
First Page PreviewforThe stubborn persistence of adult pneumococcal pneumonia as a public health problem | Full Text | References | PDF (623.8 KB)
  • 603 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Preventing non bacteremic pneumococcal pneumonia in older adults
Historical background and considerations for choosing between PCV13 and PPV23
David S Fedson
Pages: 1322-1330
Published online: 14 Apr 2014
First Page PreviewforPreventing non bacteremic pneumococcal pneumonia in older adults | Full Text | References | PDF (678.1 KB)
  • 1389 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access

Commentary

The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries
Daniel M Musher & Maria C Rodriguez-Barradas
Pages: 1331-1333
Published online: 30 Apr 2014
AbstractforThe CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries | Full Text | References | PDF (601 KB)
  • 1336 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Pneumococcal conjugate vaccines for adults
Reasons for optimism and for caution
Daniel M Weinberger & Eugene D Shapiro
Pages: 1334-1336
Published online: 24 Apr 2014
First Page PreviewforPneumococcal conjugate vaccines for adults | Full Text | References | PDF (595 KB)
  • 724 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies
Emanuele Amodio, Claudio Costantino, Sara Boccalini, Fabio Tramuto, Carmelo M Maida & Francesco Vitale
Pages: 1337-1342
Published online: 27 Feb 2014
AbstractforEstimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies | Full Text | References | PDF (1.9 MB)
  • 853 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults
A randomized open-label trial
Christine Juergens, Pierre JT de Villiers, Keymanthri Moodley, Deepthi Jayawardene, Kathrin U Jansen, Daniel A Scott, Emilio A Emini, William C Gruber & Beate Schmoele-Thoma
Pages: 1343-1353
Published online: 27 Feb 2014
AbstractforSafety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults | Full Text | References | PDF (1.3 MB)
  • 2205 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access
Article
Assessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans
Hardanahalli S Ravish, Mysore K Sudarshan, Shampur N Madhusudana, Rachana R Annadani, Doddabele H Ashwath Narayana, Ashwin Y Belludi, Gangaboraiah Anandaiah & Veena Vijayashankar
Pages: 1354-1358
Published online: 28 Feb 2014
AbstractforAssessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans | Full Text | References | PDF (634.3 KB)
  • 2656 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Development and evaluation of a new immunohistochemistry-based test for the detection of rabies virus neutralizing antibodies
Shampur N Madhusudana, Bhavana V Malavalli, Ullas P Thankappan, Subha Sundramoorthy, Ashwin Y Belludi, Srinivasa B Pulagumbaly & Sampada Sanyal
Pages: 1359-1365
Published online: 27 Feb 2014
AbstractforDevelopment and evaluation of a new immunohistochemistry-based test for the detection of rabies virus neutralizing antibodies | Full Text | References | PDF (1 MB)
  • 1124 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial
Yi-Juan Chen, Fan-Yue Meng, Qunying Mao, Jing-Xin Li, Hua Wang, Zheng-Lun Liang, Yun-Tao Zhang, Fan Gao, Qing-Hua Chen, Yuemei Hu, Zi-Jun Ge, Xin Yao, Hui-Jie Guo, Feng-Cai Zhu & Xiu-Ling Li
Pages: 1366-1372
Published online: 14 Mar 2014
AbstractforClinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial | Full Text | References | PDF (856.2 KB)
  • 1810 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access
Article
Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009–2010
Preeta Krishnan Kutty, Jacqueline Lawler, Elizabeth Rausch-Phung, Ismael R Ortega-Sanchez, Stephen Goodell, Cynthia Schulte, Lynn Pollock, Barbara Valure, Jean Hudson, Kathleen Gallagher & Debra Blog
Pages: 1373-1381
Published online: 14 Mar 2014
AbstractforEpidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009–2010 | Full Text | References | PDF (767.6 KB)
  • 1600 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Safety and immunogenicity of a live attenuated mumps vaccine
A phase I clinical trial
Yan Liang, Jingchen Ma, Changgui Li, Yuguo Chen, Longding Liu, Yun Liao, Ying Zhang, Li Jiang, Xuan-Yi Wang, Yanchun Che, Wei Deng, Hong Li, Xiaoyu Cui, Na Ma, Dong Ding, Zhongping Xie, Pingfang Cui, Qiuyan Ji, Jingjing Wang, Yuliang Zhao, Junzhi Wang & Qihan Li
Pages: 1382-1390
Published online: 10 Mar 2014
AbstractforSafety and immunogenicity of a live attenuated mumps vaccine | Full Text | References | PDF (1.1 MB) | Supplemental
  • 1129 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Toward a mechanism-based in vitro safety test for pertussis toxin
Stefan FC Vaessen, Martijn WP Bruysters, Rob J Vandebriel, Saertje Verkoeijen, Rogier Bos, Cyrille AM Krul & Arnoud M Akkermans
Pages: 1391-1395
Published online: 19 Feb 2014
AbstractforToward a mechanism-based in vitro safety test for pertussis toxin | Full Text | References | PDF (653.6 KB)
  • 805 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States–Mexico Border
Kacey C Ernst & Laura M Erhart
Pages: 1396-1403
Published online: 06 Mar 2014
AbstractforThe role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States–Mexico Border | Full Text | References | PDF (883.8 KB)
  • 591 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Letter

Article Commentary
An age-related decline of CD62L and vaccine response
A role of microRNA 92a?
Jae Il Shin & Jagadeesh Bayry
Pages: 1404-1405
Published online: 08 Jan 2014
AbstractforAn age-related decline of CD62L and vaccine response | Full Text | References | PDF (581.4 KB)
  • 588 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Reply Letter

Reply to Shin and Bayry on “An age-related decline of CD62L and vaccine response: a role of microRNA 92a?”
Thomas Vorup-Jensen, Carina Rosenberg & Eskild Petersen
Pages: 1406-1407
Published online: 11 Feb 2014
AbstractforReply to Shin and Bayry on “An age-related decline of CD62L and vaccine response: a role of microRNA 92a?” | Full Text | References | PDF (1.1 MB)
  • 446 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Completeness and timeliness of vaccination and determinants for low and late uptake among young children in eastern China
Yu Hu, Yaping Chen, Jing Guo, Xuewen Tang & Lingzhi Shen
Pages: 1408-1415
Published online: 28 Feb 2014
AbstractforCompleteness and timeliness of vaccination and determinants for low and late uptake among young children in eastern China | Full Text | References | PDF (775 KB) | Supplemental
  • 3519 Views
  • 60 CrossRef citations
  • 0Altmetric
Free Access
Article
Communication about vaccinations in Italian websites
A quantitative analysis
Silvio Tafuri, Maria S Gallone, Maria F Gallone, Ivan Zorico, Valeria Aiello & Cinzia Germinario
Pages: 1416-1420
Published online: 07 Mar 2014
AbstractforCommunication about vaccinations in Italian websites | Full Text | References | PDF (627.3 KB)
  • 1488 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine
A preliminary report of re-analyses of data from a Cochrane Database Systematic Review
Masato Takeuchi
Pages: 1421-1424
Published online: 07 Mar 2014
AbstractforBayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine | Full Text | References | PDF (631.9 KB) | Supplemental
  • 1132 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Explore articles